TrialMolecular and cellular biology2022

The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients.

Megan McAleavy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.